Published on :
Outbreaks of Ebola virus disease occur periodically in several countries in sub-Saharan Africa. Since September 20, 2022, an epidemic has been raging in Uganda.
The first doses of candidate vaccine had been sent to the site at the beginning of December 2022, to curb the emerging infection of the so-called “Sudanese” strain. The last case having been reported on November 30, this January 10, 2023 marks the theoretical end of this Ugandan outbreak which has infected 142 people, including 77 fatal cases.
During this program, we will also report on the promising results concerning the safety and the immune response induced by vaccination once morest Ebola.
- Pr Eric Delaporte, professor of infectious diseasesMontpellier University and director of a research unit at theIRD and theInserm on AIDS and emerging diseases.
- Dr. Freddy Banza Mutoka, Head of Health Operations for the Ebola Response in Uganda. Responsible for the preparation and response of countries to public health emergencies at the Regional Office of theWHO Africa.
- Pr Yazdan Yazdanpanah, head of the infectious diseases department at theBichat Hospitaldirector of studies at theInserm.
